| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Atherosclerosis and Lipoproteins |
From the Department of Immunology (R.E.T., B.P., R.P., Y.S., L.K.C., N.M.), The Scripps Research Institute, La Jolla, Calif; the Department of Cell Biology (N.M.), The Scripps Research Institute, La Jolla, Calif; University of New South Wales (J.H.E.), Sydney, Australia; the Department of Internal Medicine (Y.S., S.D., Y.H., D.T.E.), University of Michigan Medical School, Ann Arbor, Mich; the Department of Vascular Medicine Research (W.A.B.), Harvard Medical School, Cambridge, Mass; and the Department of Internal Medicine (W.P.F.), University of Missouri at Columbia, Mo.
Correspondence to Nigel Mackman, The Scripps Research Institute,10550 North Torrey Pines Road, CVN-18, La Jolla, CA 92037. E-mail nmackman{at}scripps.edu
Objective To determine whether tissue factor (TF) contributes to the progression of atherosclerotic lesions in mice.
Methods and Results We determined the effect of a 50% reduction of TF levels in all cells on atherosclerosis in apolipoprotein E-deficient (apoE/) mice. No differences were observed in the extent of atherosclerosis in apoE//TF+/+ and apoE//TF+/ mice fed regular chow for 34 weeks. Atherosclerosis could not be analyzed in apoE/ mice expressing low levels of TF because of premature death of these mice. Macrophages are a major source of TF in atherosclerotic plaques. Therefore, in a second series of experiments, we investigated the effect on atherosclerosis of selectively reducing hematopoietic cell-derived TF by transplanting bone marrow from mice expressing low levels of TF into low-density lipoprotein receptor deficient (LDLR/) mice. Atherosclerosis within the arterial tree and aortic root were similar in LDLR/ mice with low-TF bone marrow compared with control bone marrow (TF+/+ or TF+/) after 4 and 16 weeks on an atherogenic diet. Furthermore, the cellular composition of the aortic root lesions was similar between the 2 groups.
Conclusions Our data indicate that either a 50% reduction of TF in all cells or a selective reduction in hematopoietic cell-derived TF does not affect the development of atherosclerotic lesions in mice.
We sought to determine whether tissue factor (TF) contributes to the progression of atherosclerotic lesions in mice. A 50% reduction of TF in all cells or a selective reduction of TF in hematopoietic cells does not affect the development of atherosclerotic lesions in 2 mouse models. TF does not contribute to the progression of atherosclerosis in mice.
Key Words: atherosclerosis macrophages mice tissue factor
This article has been cited by other articles:
![]() |
N. Mackman and M. B. Taubman Does Tissue Factor Expression by Vascular Smooth Muscle Cells Provide a Link Between C-Reactive Protein and Cardiovascular Disease? Arterioscler Thromb Vasc Biol, April 1, 2008; 28(4): 601 - 603. [Full Text] [PDF] |
||||
![]() |
K. M. Wilson, R. B. McCaw, L. Leo, E. Arning, S. Lhotak, T. Bottiglieri, R. C. Austin, and S. R. Lentz Prothrombotic Effects of Hyperhomocysteinemia and Hypercholesterolemia in ApoE-Deficient Mice Arterioscler Thromb Vasc Biol, January 1, 2007; 27(1): 233 - 240. [Abstract] [Full Text] [PDF] |
||||
|
ATVB Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2006 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |